TR Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TR Corporation - overview
Established
2020
Location
Daejeon, -, South Korea
Primary Industry
Healthcare IT
About
Based in Daejeon, South Korea, and founded in 2020, TR Corporation operates as a digital healthcare company specializing in developing medical devices and electronic products. In May 2026, TR Corporation raised an undisclosed amount of venture funding from new investors Daewoong Pharmaceutical and Naver. As of January 2026, the company is led by its CEO Byeong-su Kim. TR Corporation's flagship offering is Spirokit, an AI-based screening system that boasts precision akin to established lung function testers in university hospitals.
It allows for convenient testing anywhere using smart devices, catering to primary and secondary medical institutions and empowering individual respiratory disease management. Additionally, it provides Mechano Tape, a domestically developed medical device, that addresses blood pooling issues, aiding joint and muscle movement. The company will use the May 2026 funding to further strengthen its position in the domestic respiratory diagnostic market.
Current Investors
MMS Ventures, AhealthZ Corp., Korea Credit Guarantee Fund
Primary Industry
Healthcare IT
Sub Industries
Consulting Services, Recreational Hobbies & Sporting Goods, Healthcare IT, Medical Devices & Equipment, Pharmaceutical Research & Development
Website
www.theresearcher.co.kr/
Verticals
Artificial Intelligence, HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
TR Corporation - financials
| Fiscal Year Ended | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|
| Revenue (USD) | - | - | - |
| % Revenue Growth (YoY) | - | - | - |
| EBITDA (USD) | - | - | - |
| Operating Income (USD) | - | - | - |
| Operating Margin | - | - | - |
| % EBITDA Margin | - | - | - |
| NET Income (USD) | - | - | - |
| % Net Margin | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.